Combined preparation for the therapy of immune diseases

US6337325B1 · kind B1 · utility

Assignee

• Hoechst GmbH · DE

Inventors

• Martin Schönharting · Taunusstein, DE
• Stefan Mullner · Langenfeld, DE
• Peter Zabel · Bad Segeberg, DE

Key dates

• Filing date: Jul 20, 1999
• Grant date: Jan 8, 2002
• Expiry date: Jul 20, 2019

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P37/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A combination preparation comprising a compound which has a phosphodiesterase-inhibiting action, and a compound which reduces the biologically effective intracellular Ca2+ content, is suitable for the treatment of immunological diseases.